These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8301302)

  • 21. Immunotherapy in multiple sclerosis, Part 1.
    Becker CC; Gidal BE; Fleming JO
    Am J Health Syst Pharm; 1995 Sep; 52(18):1985-2000. PubMed ID: 8528866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunodepressants used in immune system pathology. I. Cyclosporin, cyclophosphane, azathioprine and mercaptopurine].
    Napolov IuK; Borisov KB
    Farmakol Toksikol; 1991; 54(4):80-7. PubMed ID: 1786839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis therapy. A practical guide.
    van Oosten BW; Truyen L; Barkhof F; Polman CH
    Drugs; 1995 Feb; 49(2):200-12. PubMed ID: 7729328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status and future prospective of immunointervention in multiple sclerosis.
    Cavaletti G
    Curr Med Chem; 2006; 13(19):2329-43. PubMed ID: 16918358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG].
    Rieckmann P; Toyka KV
    Eur Neurol; 1999; 42(3):121-7. PubMed ID: 10529535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of multiple sclerosis].
    Livrea P
    Acta Neurol (Napoli); 1989; 11(2-3):165-85. PubMed ID: 2675538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. More immunotherapy for multiple sclerosis.
    Hughes RA; Sharrack B
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):239-41. PubMed ID: 8795592
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppressive agents in dermatology.
    Ho VC; Zloty DM
    Dermatol Clin; 1993 Jan; 11(1):73-85. PubMed ID: 8435920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive drugs in multiple sclerosis: pro and con.
    Ellison GW; Myers LW
    Neurology; 1980 Jul; 30(7 Pt 2):28-32. PubMed ID: 6248818
    [No Abstract]   [Full Text] [Related]  

  • 30. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.
    Gout O
    Ann Neurol; 2008 Jan; 63(1):126; author reply 126-7. PubMed ID: 17702028
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiple sclerosis trials.
    Kappos L
    Lancet; 1999 Jun; 353(9171):2242-3. PubMed ID: 10393009
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunosuppressive therapy of multiple sclerosis using cyclophosphamide and imuran. Report on 57 cases].
    Göpel W; Benkenstein H; Banzhaf M
    Dtsch Gesundheitsw; 1972 Oct; 27(41):1955-61. PubMed ID: 4637249
    [No Abstract]   [Full Text] [Related]  

  • 33. Indirect meta-analytical comparison of azathioprine and of beta interferon effectiveness in all forms of multiple sclerosis pooled together.
    Messori A; Fadda V; Maratea D; Trippoli S
    J Neurol Sci; 2014 Dec; 347(1-2):408-10. PubMed ID: 25455308
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunosuppressive medication in multiple sclerosis].
    García Merino JA
    Rev Neurol; 2002 Dec 16-31; 35(12):1154-8. PubMed ID: 12497298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sclerosis.
    Boggild M; Ford H
    Clin Evid; 2004 Dec; (12):1843-60. PubMed ID: 15865753
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon beta in multiple sclerosis. Interferon beta reduces overall relapse rate by one third.
    Napier JC
    BMJ; 1997 Feb; 314(7080):601. PubMed ID: 9055729
    [No Abstract]   [Full Text] [Related]  

  • 37. [Multiple sclerosis--recent advances in pathogenesis and treatment].
    Itoyama Y; Fujihara K; Nakashima I; Misu T; Fujimori T; Sato S
    No To Shinkei; 2002 Jan; 54(1):5-21. PubMed ID: 11868352
    [No Abstract]   [Full Text] [Related]  

  • 38. New treatments and azathioprine in multiple sclerosis.
    Palace J; Rothwell P
    Lancet; 1997 Jul; 350(9073):261. PubMed ID: 9242805
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunological treatment of multiple sclerosis. II.
    Hughes RA
    J Neurol; 1986 Apr; 233(2):66-8. PubMed ID: 3009722
    [No Abstract]   [Full Text] [Related]  

  • 40. Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.
    Mabrouk D; Gürcan HM; Keskin DB; Christen WG; Ahmed AR
    Ann Pharmacother; 2010 Nov; 44(11):1770-6. PubMed ID: 20923942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.